Park Square has placed Beth Marsh as Chief Commercial Officer at Neurotech Pharmaceuticals.
Neurotech Pharmaceuticals, Inc., a private biotech company focused on developing transformative therapies for chronic eye diseases, announced the appointment of Beth Marsh as Chief Commercial Officer, effective April 28, 2025.
unknownx500
More posts by Park Square Executive Search
Recent posts from Park Square Executive Search
